March 13, 2024 · Form 4 insider transaction
LIERMAN TERRY L bought 150,000 shares of IGC Pharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents 150,000 options to buy shares of common stock, 50,000 vesting immediately and 100,000 subject to vesting over two years in equal parts starting 2025, as per the IGC Board of Directors Agreement with Mr. Lierman.; Exercisable in equal amounts on March 2024, 2025 & 2026.